Cameroon vs India: HIV-positive TB patients on ART (antiretroviral therapy)
Cameroon
98.0%
in 2024
India
98.0%
in 2024
Cameroon rank
64th
India rank
64th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Cameroon
- India
How they compare
Cameroon currently reports 98.0% against 98.0% in India, a difference of 0.0%.
The two have swapped places 5 times across 18 shared years of data; in 2007 it was Cameroon ahead.
Cameroon ranks 64th and India ranks 64th of 144 countries.
Across the 3 decades both report, Cameroon averaged higher in 2 and India in 1.
Head to head by decade
| Decade | Cameroon | India | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.0% | 30.9% | 10.1% | Cameroon |
| 2010s | 78.7% | 81.1% | 2.4% | India |
| 2020s | 98.2% | 96.8% | 1.4% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Cameroon or India?
- Cameroon, at 98.0% against 98.0% in India as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Cameroon and India?
- 0.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and India?
- 18 years are reported by both, from 2007 to 2024.
- How do Cameroon and India rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Cameroon ranks 64th and India ranks 64th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.